Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	492.20	407.25	68.77
Graham Fair Price	-51.86	1.28	2.66
PEG	1878.87	-1.55	0.08
Price/Book	-7.94	3.24	3.52
Price/Cash Flow	19.67	-23.32	19.49
Prices/Earnings	303.34	119.18	29.55
Price/Sales	21.80	13.17	10.82
Price/FCF	19.67	-23.32	19.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-53.54	0.12	0.25
Operating Margin	-85.38	-0.01	0.10
ROA	-77.20	< 0.005	0.01
ROE	0.03	< 0.005	-77.17
ROIC	0.03	< 0.005	-91.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	32.05	-0.91	3419.11
Dividends QOQ	0.43	-0.55	26.62
EBIT QOQ	5.83	-1.11	-80.93
EPS QOQ	3.78	-0.77	-79.62
FCF QOQ	0.38	-1.78	372.77
Revenue QOQ	0.11	-0.24	121.30
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	91.27	103.84	13.78
Days Sales Outstanding (DSO)	112.16	165.53	47.58
Inventory Turnover	0.99	0.87	-12.11
Debt/Capitalization	< 0.005	0.21	2497.12
Quick Ratio	0.95	0.90	-5.58
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.25	3.28	0.75
Cash	2.06	1.76	-14.48
Capex	-0.03	-0.02	48.00
Free Cash Flow	0.59	-0.46	-22.49
Revenue	1.06	0.81	-23.85
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.27	-3.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-15.25	-33.54	-119.95
Naive Interpretation	Member

06 - Financial Health · Weak

Rating